Medindia LOGIN REGISTER
Medindia

Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug

by Kathy Jones on Apr 1 2013 6:05 PM

 Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug
Swiss pharmaceutical giants Novartis has received a huge blow to its Indian operations after the country’s Supreme Court dismissed a patent request for its cancer drug, Glivec.
The Supreme Court ruled that the compound for which Novartis was seeking a patent "did not satisfy the test of novelty or inventiveness" required by Indian law.

Source-AFP


Advertisement